Avtal | $24,000,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
Certified by Founder
Lodge
GRO Biosciences
start up
United States
- Boston, MA
- 23/07/2024
- Series B
- $60,300,000
GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.
- Industry Pharmaceutical Manufacturing
- Website https://grobio.com/
- LinkedIn https://www.linkedin.com/company/grobio/
Related People
Dan MandellCo Founder
United States -
Boston, Massachusetts
Expanding the amino acid alphabet to make better medicines. Experienced Chief Executive Officer and scientist with a demonstrated history of technology development. Strong business development professional skilled in Computational Biology, Protein Chemistry, Entrepreneurship, Molecular Biology, and Metabolic Engineering.
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)